Objectives. Inflammatory arthritides/synovitides such as psoriatic (PsA), reactive (ReA) and rheumatoid (RA) arthritis share numerous immunopathological features, but develop different patterns of joint involvement. To investigate whether distinctive cell apoptosis may play a role in this context, we have assessed synovial cell apoptosis in situ in PsA and ReA, and compared it with RA and 'non-inflammatory' controls.
morphofunctional characteristics of a given tissue. elbow joints) were obtained at their open-joint surgery or diagnostic arthroscopy. These same synovial samples Adequate apoptosis is an important part of normal physiological processes such as tissue development, were used in a previous study [25] . Eight of the patients (two men and six women; mean age 47 yr, range 31-73) involution, maintenance of tissue homeostasis and immunoregulation. Disturbance in the apoptosis of had RA [31] (mean duration of the arthritis 7.8 yr, range 3-15), eight (six men and two women; mean age specific cells has been implicated in the development of cancer, in persistence or dissemination of some viral 32.6 yr, range 7-43) had PsA [18] (mean duration of the arthritis 7.4 yr, range from 4 months to 25 yr) and infections, ischaemic injury, degenerative neural diseases, autoimmune conditions and rheumatoid arthritis seven (two men and five women; mean age 33.4 yr, range had ReA [duration of the arthritis 3 days (RA) [1] [2] [3] [4] .
It is assumed that, in RA, an imbalance between cell (two cases), 6 months (one case), 1 yr (one case), 2.5 yr (one case), 3 yr (one case), and in one case recurrent apoptosis and cell influx, along with cell proliferation in situ [5, 6 ] , may account for synovial lining and inflamknee monoarthritis for 12 yr]. Specimens from six patients (three men and three women; mean age 41.2 yr, matory cell hyperplasia, the features believed to be relevant to the development of joint erosion or persistrange 28-63) served as 'non-inflammatory' controls; these synovial samples were from joints with ence of rheumatoid inflammation, or both [7, 8] . Indirect support for this hypothesis comes from the studies osteoarthritis (OA) (n = 2) [32] , meniscus lesion (n = 2), distortion of the knee joint (n = 1) and knee demonstrating apoptotic synovial cells and an eventual disturbance in some of the apoptosis-regulatory pathchondromatosis (n = 1). All patients with PsA had psoriatic skin disease and ways in RA [8] [9] [10] [11] [12] [13] [14] [15] [16] . Nonetheless, the histo-and clinicopathological relevance of these disturbances in were negative for rheumatoid factor. Of the patients with ReA, arthritis had been triggered by chlamydial synovial cell apoptosis in RA is obscure, because it remains unknown which of them are 'primary' and infection in five cases, and in one by Salmonella infection, and in one case ReA had developed after pharynwhich are merely 'secondary' (inflammation related). It is apparent in this context that comparative studies gitis (no Salmonella, Yersinia, Campylobacter or chlamydial antibodies were found in this patient's between synovial cell apoptosis and its regulation in various inflammatory arthritides, including RA, psoriblood ). Synovial fluid cultures of ReA patients were negative. Five of the ReA patients were HLA B27+. atic (PsA) and reactive (ReA) [17] [18] [19] , may be helpful in elucidating this issue.
All ReA patients recovered during the follow-up. Of these 29 patients, none had previously undergone Although synovial and immunocompetent cell responses in PsA and ReA share numerous immunosynovectomy. Of the RA patients, four had been receiving daily non-steroidal anti-inflammatory drugs pathological characteristics with RA [20] [21] [22] [23] [24] [25] , the clinical pattern of joint involvement in RA is distinct in that it (NSAID) alone, one chloroquine (DelagilA, 200 mg) + NSAID, one steroids (7.5 mg equivalent to prednisois almost always characterized by erosion of hard tissues such as cartilage and subchondral bone. The destructive lone), one sulphasalazine (1.5 mg) + steroids (10 mg equivalent to prednisolone) + NSAID; one of the nature of RA may, to a large extent, be dependent on synovial tissue which undergoes 'mesenchymoid trans-RA patients received no systemic medication. Of PsA patients, one had been receiving sulphasalazine formations' (e.g. aberrant expression of oncogenes, disturbance in the turnover of specific cells/cell prolifera-(1.5 g) + NSAID, one allopurinol + NSAID, two NSAID alone, and four received no systemic medication. tion) and, as a result, acquires destructive capacity against cartilage and bone. It is interesting, however, Of the patients with ReA, two received no medication, five had been receiving NSAID; in one of the latter, that such anticipations, based on RA studies, have not been supported by recent comparative studies of antibacterial therapy had been initiated prior to synovial biopsy. Of the 'non-inflammatory' control patients, five inflammatory arthritides. For example, these recent studies have revealed that in situ proliferation of synovial had been receiving NSAID and one received no systemic medication. lining fibroblasts and synovial expression of numerous oncogenes, including those associated with cell turnover Detection of apoptotic cells/TUNEL staining [25] [26] [27] [28] [29] [30] For detection of apoptotic cells, a slightly modi-( Fluka), briefly dried, and mounted with aqueous mounting media Glycergel (Dako, Glostrup, Denmark), fied TdT-mediated dUTP-biotin nick end-labelling ( TUNEL) method was applied, based on TdT-mediated or not counterstained, but processed by immunostaining (see below). labelling of 3∞-OH DNA ends exposed in apoptotic cells [33, 34] . Briefly, 5-mm-thick serial sections from the Double TUNEL/CD68 and TUNEL/LCA formalin-fixed paraffin-embedded synovial samples were immunostaining applied to APES (3-aminopropyl-triethoxysilane, from Sigma)-coated slides. Before staining, sections were After TUNEL staining (see above), the sections were rinsed in distilled water three times for 5 min, following heated at +60°C for 30 min, cooled, deparaffinized in xylene and dehydrated in absolute ethanol. Further, the by a wash in 0.1  phosphate-buffered saline (PBS ), pH 7.4. Then the sections were serially incubated/treated sections were treated with a solution of absolute ethanol/ acetic acid (2:3) for 20 min, with 5% H 2 O 2 in methanol with: (1) normal horse serum (diluted 1:50; Vector Laboratories, Burlingame, CA, USA) for 45 min; for 30 min, 94% methanol twice for 5 min, and 70% methanol for 5 min, and were left in 70% methanol (2) primary antibody (for 1 h), a monocyte/macrophage marker mouse anti-human CD68 IgG (dilution 1:50, overnight at +4°C. The sections were rinsed in graded methanol series (50% and 30%) and in PBT (phosphateDako) or mouse anti-human leucocyte common antigen (LCA; clones 2B11 and PD7/26, Dako, diluted 1:75), buffered saline containing 0.1% Triton X-100).
Cells in the tissue sections were permeabilized by which reacts with epitopes on LCA chains with a molecular mass of 180, 190, 205, 220 kDa, labelling application of a proteinase K 7 mg/ml (staining-to-noise ratio optimized by testing different proteinase K concenmainly lymphoid, but not non-haematopoietic cells (for references, see antibody specification) [this antibody is trations, such as 7, 14 and 21 mg/ml ) solution in 50 m Tris-HCl and 5 m EDTA for 10 min at room tempernot designed as a CD45 and, in contrast to many other lymphoid and myeloid cell markers, is particularly ature. The sections were rinsed twice for 5 min with PBT and post-fixed in fresh 4% PFA for 20 min. PFA recommended for use on routinely processed, paraffinembedded specimens]; (3) secondary biotinylated horse was removed by two subsequent 5 min rinses in PBT.
TdT-mediated labelling of the fragmented DNA presanti-mouse IgG (diluted 1:130; Vector Laboratories) for 45 min; (4) avidin-biotin-peroxidase complex (diluted ent in the apoptotic cells was carried out in a humidified box at +37°C by incubating tissue sections for 1 h 1:100, Vector Laboratories) for 30 min; (5) 3,3∞-diaminobenzidine tetrahydrochloride (DAB) (Sigma) in in labelling mixture prepared freshly in the TdT buffer. The labelling mixture consisted of: (1) 1 n 0.006% H 2 O 2 PBS solution. After being washed in tap water, the sections were rinsed in distilled water and Dig-11-dUTP; (2) 1 n dATP; (3) 0.5% CHAPS; (4) 20 U TdT/75 ml of mixture. The labelling was terminmounted in aqueous mounting media Glycergel (Dako). BSA, 0.1% in PBS, was used for dilution of serum and ated by transfer of the sections into 300 m NaCl, 30 m sodium citrate and 0.1% CHAPS for 15 min, and antibodies. Between each step (except after incubation with normal goat serum), the slides were rinsed three then by two subsequent rinses (for 20 min in total ) with gentle rocking in TBT 0.1% CHAPS. Then, the sections times for 5 min in PBS. Omission of the primary antibody (for procedure control ), use of normal mouse were pre-blocked with 10% goat serum and 2% BSA in TBT overnight in a humidified box. Mouse embryo IgG 1 instead of specific primary antibodies (for specificity of the staining) and exposure of tissue sections to powder was made and alkaline phosphatase-conjugated anti-digoxigenin antibody was pre-absorbed as described DAB alone (for endogenous peroxidase) served as negative staining controls. elsewhere [33] .
After the pre-blocking solution was drained off, preMicroscopic evaluation and quantitative assessment of absorbed anti-digoxigenin antibody was applied onto the synovial labelling sections and left overnight at +4°C in a humidified box.
Sections were rinsed with TBT ( Tris-buffered saline, Microscopic examination and cell counting were carried out with the Leitz Diaplan lens system ( Wetzlar, containing 0.1% Triton X-100) three times for 5 min, then three times for 30 min under continuous rocking.
Germany). Morphological assessment of synovial lining hyperplasia and the extent of inflammation were by Thereafter, sections were rinsed for 5 min in alkaline phosphatase buffer (NTM ), then rinsed twice for 5 min reference to the commonly utilized semiquantitative histological grading as follows. Synovial lining hyperplaunder continuous rocking in NTM containing 2 m levamisole (to inhibit endogenous alkaline phosphatase).
sia: no hyperplasia (1-2 cell layers thick), minimal hyperplasia (3-5 cell layers thick), moderate lining Staining was developed by applying to the sections a freshly prepared mixture of 338 mg/ml NBT (75 mg/ml hyperplasia (6-9 cell layers thick) and marked lining hyperplasia (Á 10 cell layers thick). Inflammatory monosolution in 70% dimethylformamide) and 175 mg/ml BCIP (50 mg/ml solution in absolute dimethylformamnuclear cell infiltration was graded as follows: no infiltrate, minimal infiltration, moderate infiltration (diffuse ide) in NTM. The colour reaction was monitored under and/or presence of aggregated perivascular infiltrates), somal condensation, nuclear fragmentation or eosinomarked infiltration (diffuse and/or presence of many philic change in the cytoplasm [11] , suggesting the aggregated perivascular infiltrates).
presence of cells undergoing different stages of apoptosis. Assessment of synovial cell apoptosis ( TUNEL stain-TUNEL staining/apoptotic cells were observed in ing) was performed separately (1) in the synovial lining, synovial lining and stromal (i.e. sublining and perivascuwhere the cells were counted through the whole thickness lar) locations (Figs 1-3 ). It should be noted, however, of the synovial lining, not the intimal monolayer only, that in PsA apoptotic cells were preferentially situated and (2) in the synovial stroma comprising sublining in the lining ( Fig. 2) , whereas, as assessed by semiquanareas and perivascular inflammatory cell infiltrates (in titative scoring of apoptotic cell distribution in the the inflammatory samples) up to the fibrocapsular tissue.
synovial stroma (see Table 1 ), in RA ( Fig. 1) -and in In each of these two locations, 1000 consecutive cells ReA (Fig. 3) in particular-sublining areas adjacent to were counted in the 3-4 consecutive synovial sections.
inflammatory cell infiltrates were also rich in apoptotic The average percentage of the apoptotic lining and cells. In contrast to scattered apoptotic synovial lining stromal cells was estimated separately for data presentacells in PsA and ReA ( Figs 2 and 3) , in five RA cases tion in each case. Synovial stromal cell apoptosis was apoptotic cells were found clustered in limited areas of assessed for its distribution to evaluate the presence of synovium ( Fig. 1D) ; in fact, these RA cases were characcell apoptosis separately in the sublining and in the terized by high numbers of apoptotic lining cells (see inflammatory infiltrates as follows: 0, no cell apoptosis; Fig. 4 Frequency of the synovial cell apoptosis in RA, PsA and Each cell counting was performed by two observers, ReA independently, one of whom was unaware of the Quantitative results of the TUNEL staining appear in patients' identities or source of the sample. (Q3-Q1) = 1.0%] were significantly higher (P < 0.05) Medians plus interquartile ranges (Q3-Q1) were used than in controls [median 0.1% (Q3-Q1) = 0.15%]. There for data presentation. The Siegel-Tukey test for scale were no statistically significant differences between RA, difference served for comparison of the groups.
PsA and ReA in this respect (P > 0.05). Each of three Differences were considered significant at P ∏ 0.05.
RA cases, a subset with a notably lesser (and very similar) extent of apoptotic lining cells, showed moderate Results lining hyperplasia (Fig. 4) , whereas another subset of RA samples, showing a notably greater extent of lining Standard histology cell apoptosis, included cases with the differing degrees Of the eight RA cases, two revealed marked, four of lining hyperplasia (Fig. 4) . moderate, one minimal and one no synovial lining
The percentages of apoptotic cells in the synovial hyperplasia. In contrast, two of the seven ReA and five stroma (sublining + inflammatory mononuclear cell-rich of the eight PsA cases showed no lining hyperplasia. Of areas) in RA [median 2.0% (Q3-Q1) = 2.3%], PsA the seven ReA, five, and two of the eight PsA cases [median 1.1% (Q3-Q1) = 0.7%] and ReA [median 3.2% showed minimal and only one PsA case moderate lining (Q3-Q1) = 2.4%] were significantly higher (P < 0.05) hyperplasia. Perivascular inflammatory cell infiltration than in controls [median 0.6% (Q3-Q1) = 0.75%]. was very similar in RA, ReA and PsA samples. Of the Control samples showed none or only occasional eight RA cases, two showed moderate, five marked and inflammatory cells, but the numbers of stromal cells one minimal perivascular infiltration. Of the seven ReA were high enough for quantitative assessment. In cases, five showed moderate and two marked inflamaddition, the percentage of apoptotic inflammatory matory cell infiltrates. Of the eight cases with PsA, one cells was higher in ReA than in RA (P = 0.002) or showed minimal, five moderate and two marked periPsA (P = 0.02), differences which were, apparently, vascular infiltration. (Case-referent description of these accounted for by the differences in extent of sublining morphological features and the extent of the cell cell apoptosis in PsA, ReA and RA (see Table 1 ). The apoptosis is given in Fig. 5.) percentages of apoptotic inflammatory cells were similar Cellular pattern and synovial distribution of the TUNEL in RA and PsA (P = 0.08). staining Representative double-staining results are illustrated in Fig. 5 . Of the apoptotic lining cells, on average 80% TUNEL showed a mixed staining pattern, which was originally described as halo ring formation, chromo-(range 70-100%) in RA, 86% (range 70-90%) in ReA and 84% (range 75-90%) in PsA were CD68+ cells. in RA. In contrast, the relevance of synovial cell apoptosis to the pathogenesis of PsA and ReA, the LCA+ apoptotic lining cells were mutually exclusive.
Of the apoptotic cells in the inflammatory monoother two inflammatory arthritides characterized by activation of the cellular immune response, has been nuclear cell-rich areas, on average, 32% (range 10-60%) in RA, 38% (range 30-50%) in ReA and 33% (range less extensively addressed. This fact prompted us to assess synovial cell apoptosis in situ in PsA and ReA, 20-40%) in PsA were LCA+ cells. As estimated from the consecutive sections, of the apoptotic cells in the and to compare it with RA and 'non-inflammatory' controls, an approach which has revealed several interesinflammatory mononuclear cell-rich areas, 70% (range 60-75%) in RA, 68% (range 60-80%) in ReA and 69% ting observations. That is, we were unable to discover any disease-specific pattern in the phenotype of apop-(range 60-80%) in PsA were CD68+ cells.
totic synovial lining cells in PsA, ReA or RA. Notably, however, apart from local aggregates, the RA synovial Discussion lining and sublining contained only a few apoptotic cells, a finding which may, in part, explain the occurrence Because of the possibly direct relationship between the development of synovial cell hyperplasia, jointof the prominent synovial lining hyperplasia distinguishing RA from ReA and PsA. On the other hand, destructive capacity and chronicity of inflammation in RA, the mechanism of synovial cell turnover in this the frequency of inflammatory cell apoptosis was relatively high in ReA, as compared to RA and PsA, disease is an area of continuing investigation. In particular, recent studies have been focused on checking the suggesting its contribution both to the downregulation of synovial inflammation and to the control over synhypothesis of impaired synovial cell apoptosis as a major contributor to synovial hyperplasia and, possibly, as a ovial lining hyperplasia in ReA.
As expected, all inflammatory arthritides showed a cause for the persistent 'immunological inflammation' frequency of apoptotic cells above that of our 'nonrevealed that the relatively high (or low) proportion of apoptotic synovial cells seen in some cases could not be inflammatory control' samples. Considering, though, that some of the patients' medications may have influexplained by the treatment given to these patients. It should also be noted that quantitative similarities or enced the extent of their synovial cell apoptosis, we have performed a case-referent analysis (not shown), which differences observed in this respect between the patient 
F. 4.
Quantitative results of TUNEL staining in synovial membranes from rheumatoid arthritis (RA; n = 8), psoriatic arthritis (PsA; n = 8), reactive arthritis (ReA; n = 7) and Control (n = 6). Ln, synovial lining area; Str, synovial stroma (sublining + cellrich inflammatory areas; in cases of Control = sublining + perivascular areas). Horizontal bars represent medians. groups/arthritides should not be a result of sampling or Only a small proportion of apoptotic cells in perivascular inflammatory infiltrates were consistently identified measurement error, or both: we used the Siegel-Tukey test for scale difference, designed for comparison of in RA, PsA and ReA as lymphoid cells. These findings are in accord with the earlier reports which show, in groups with a wide scatter of individual values, to exclude such error at the probability level given [35] .
RA, ReA, ankylosing spondylitis and OA, a relatively high expression of the apoptosis inhibitor bcl-2 in synPhenotypic characterization of cell apoptosis in synovium from different inflammatory arthritides revealed no ovial tissue lymphocytes [29, 30] . It would seem, therefore, that similar expression of the adhesion molecules differences in the type of apoptotic cells in the synovial lining in PsA, ReA or RA. Hence, although somewhat (e.g. ICAM-1 and VCAM-1) [37] , and in situ lymphocyte proliferation [25] , together with minimal lymphounexpectedly, our results appeared not to support the hypothesis that defective apoptosis of specific cells, e.g. cyte apoptosis, are in accord with immunopathological similarities between PsA, ReA and RA. However, the synovial lining fibroblasts (CD68−), may be the feature distinguishing RA from other inflammatory arthritides.
pathogenetic role of even such low numbers of apoptotic lymphocytes in perivascular areas should not be underAny suggestion of a defect in the apoptosis-regulatory mechanisms in RA [8] [9] [10] [11] [12] [13] [14] [15] [16] different arthritides demonstrated here.
